Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application

Covid19 Clinical Trial

— SourceCOVID  

Official title:

Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application: an Observational Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04670003
• Other study ID #: WP-2020-05
• Status: Completed
• Start date: January 2, 2021
• Est. completion date: March 30, 2021

Study information

• Verified date: December 2020
• Source: Weprom
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

A coronavirus pandemic began on 12/31/2019 with a first Chinese patient. As of 04/04/2020, the epidemic affects more than 190 countries with more than 50 million official contaminations and 1,251,000 deaths. (Univ J Hopkins). This virus causes a pathology ranging from simple flu-like symptoms in 80% of cases to acute respiratory distress syndromes requiring intensive care in 5% of cases and a death rate of 1.4 to 4% of cases.

Viral contamination is airborne and fecal A first epidemic wave crossed France in March / April 2020 then a second in October / November with a source of contamination which began in mid-August 2020. The sources of propagation are not well known (what places, what times, what contacts…? ) In the context of the health crisis linked to the coronavirus, knowledge of the sources of propagation of this 2nd wave is an important issue to guide end of lockdown and second lockdown policies.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 4975
• Est. completion date: March 30, 2021
• Est. primary completion date: March 30, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria:

• users of the application

• not having objected to the use of their data

Exclusion criteria:

• user who does not have a complete questionnaire

Related Conditions & MeSH terms

• Covid19

Intervention

Other:
• users
Data of users of the web-application

Locations

Country	Name	City	State
France	Institut Interrégional de Cancérologie	Le Mans

Sponsors (2)

Lead Sponsor	Collaborator
Weprom	Kelindi

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Description of the methods of contamination of patients	Data and symptomes collected by the web applications self-questionnaire (patient reported outcome)	2 months
Secondary	Evaluation in time of the spread of the virus during the 2nd epidemic wave.	Data and symptomes collected by the web applications self-questionnaire (patient reported outcome)	2 months
Secondary	Evaluation in space of the spread of the virus during the 2nd epidemic wave.	Data and symptomes collected by the web applications self-questionnaire according to ZIP code (patient reported outcome)	2 months